Check out Medtech Insight's US FDA Warning Letter Data Tracker here.
This chart lists medical device-related close-out letters posted online by the US Food and Drug Administration in October 2022. The...
Warning Letter Close-Outs – October 2022
The US FDA released one close-out letter in October, resolving a 2021 COVID-related warning letter.
More from US FDA Warning Letters
• By
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
• By
After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.
• By
Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?
• By
The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.